|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0012133,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0023977,
umls-concept:C0030705,
umls-concept:C0035525,
umls-concept:C0164662,
umls-concept:C0220847,
umls-concept:C0231221,
umls-concept:C0521451,
umls-concept:C0750729,
umls-concept:C1280500
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2005-1-17
|
|
pubmed:abstractText |
It has been suggested that the addition of ribavirin (RBV) as a part of the treatment for chronic hepatitis C virus (HCV) in HIV co-infected patients on didanosine (ddI) or stavudine (d4T) might increase the nucleoside-induced impairment of mitochondrial function.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Mitochondrial,
http://linkedlifedata.com/resource/pubmed/chemical/Didanosine,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin,
http://linkedlifedata.com/resource/pubmed/chemical/Stavudine,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2b
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
pubmed-author:BallesterosAngel LuisAL,
pubmed-author:CôtéHélèneH,
pubmed-author:ClotetBonaventuraB,
pubmed-author:FusterDanielD,
pubmed-author:GarrabouGlòriaG,
pubmed-author:LópezSòniaS,
pubmed-author:MartínezEvaE,
pubmed-author:MiróOscarO,
pubmed-author:PlanasRamonR,
pubmed-author:Rey-JolyCelestinoC,
pubmed-author:SalasAnnaA,
pubmed-author:TorJordiJ,
pubmed-author:TuralCristinaC,
pubmed-author:VidelaSebastiáS
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
969-77
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15651755-Adult,
pubmed-meshheading:15651755-Anti-HIV Agents,
pubmed-meshheading:15651755-Antiviral Agents,
pubmed-meshheading:15651755-DNA, Mitochondrial,
pubmed-meshheading:15651755-Didanosine,
pubmed-meshheading:15651755-Drug Therapy, Combination,
pubmed-meshheading:15651755-Female,
pubmed-meshheading:15651755-HIV Infections,
pubmed-meshheading:15651755-Hepatitis C, Chronic,
pubmed-meshheading:15651755-Humans,
pubmed-meshheading:15651755-Interferon-alpha,
pubmed-meshheading:15651755-Male,
pubmed-meshheading:15651755-Middle Aged,
pubmed-meshheading:15651755-Mitochondria,
pubmed-meshheading:15651755-Polyethylene Glycols,
pubmed-meshheading:15651755-Recombinant Proteins,
pubmed-meshheading:15651755-Reverse Transcriptase Inhibitors,
pubmed-meshheading:15651755-Ribavirin,
pubmed-meshheading:15651755-Stavudine,
pubmed-meshheading:15651755-Time Factors
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Mitochondrial effects of a 24-week course of pegylated-interferon plus ribavirin in asymptomatic HCV/HIV co-infected patients on long-term treatment with didanosine, stavudine or both.
|
|
pubmed:affiliation |
HIV Clinical Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autónoma de Barcelona, Barcelona, Spain.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
